NEULANDLAB Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Neuland Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹6,294.30 |
| 52 Week High | ₹7,790.00 |
| 52 Week Low | ₹2,603.60 |
| Beta | 1.02 |
| 1 Month Change | -17.49% |
| 3 Month Change | -12.57% |
| 1 Year Change | 130.54% |
| 3 Year Change | 179.45% |
| 5 Year Change | 924.38% |
| Change since IPO | 6,525.58% |
Recent News & Updates
Recent updates
Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet
Mar 15Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?
Feb 28Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)
Feb 12Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 04Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 03Read This Before Selling Neuland Laboratories Limited (NSE:NEULANDLAB) Shares
Jan 18
Shareholder Returns
| NEULANDLAB | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.9% | 1.5% | 3.0% |
| 1Y | 130.5% | 63.0% | 44.6% |
Return vs Industry: NEULANDLAB exceeded the Indian Pharmaceuticals industry which returned 63% over the past year.
Return vs Market: NEULANDLAB exceeded the Indian Market which returned 44.6% over the past year.
Price Volatility
| NEULANDLAB volatility | |
|---|---|
| NEULANDLAB Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: NEULANDLAB has not had significant price volatility in the past 3 months.
Volatility Over Time: NEULANDLAB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,554 | Davuluri Rao | www.neulandlabs.com |
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services.
Neuland Laboratories Limited Fundamentals Summary
| NEULANDLAB fundamental statistics | |
|---|---|
| Market cap | ₹80.73b |
| Earnings (TTM) | ₹3.00b |
| Revenue (TTM) | ₹15.59b |
26.9x
P/E Ratio5.2x
P/S RatioIs NEULANDLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEULANDLAB income statement (TTM) | |
|---|---|
| Revenue | ₹15.59b |
| Cost of Revenue | ₹7.34b |
| Gross Profit | ₹8.25b |
| Other Expenses | ₹5.25b |
| Earnings | ₹3.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 233.89 |
| Gross Margin | 52.92% |
| Net Profit Margin | 19.25% |
| Debt/Equity Ratio | 6.4% |
How did NEULANDLAB perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield6%
Payout RatioDoes NEULANDLAB pay a reliable dividends?
See NEULANDLAB dividend history and benchmarks| Neuland Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Jul 12 2024 |
| Dividend Pay Date | Aug 30 2024 |
| Days until Ex dividend | 50 days |
| Days until Dividend pay date | 99 days |
Does NEULANDLAB pay a reliable dividends?
See NEULANDLAB dividend history and benchmarks